2 weeks Ago By ABMN Staff
Prudential Financial Inc. cut its holdings in STAAR Surgical ( NASDAQ:STAA – Free Report ) by 1.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission.
The fund owned 50,570 shares of the medical instruments supplier’s stock after selling 980 shares during the period. Prudential Financial Inc.’s holdings in STAAR Surgical were worth $1,348,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in STAA. Quarry LP acquired a new stake in STAAR Surgical in the 3rd quarter valued at $50,000. KLP Kapitalforvaltning AS acquired a new stake in shares of STAAR Surgical in the fourth quarter valued at about $180,000.
FMR LLC raised its holdings in STAAR Surgical by 79.3% during the third quarter. FMR LLC now owns 7,092 shares of the medical instruments supplier’s stock worth $263,000 after acquiring an additional 3,136 shares in the last quarter.
Quantbot Technologies LP acquired a new position in STAAR Surgical during the fourth quarter valued at approximately $278,000. Finally, Y Intercept Hong Kong Ltd bought a new position in STAAR Surgical in the fourth quarter valued at approximately $292,000. Institutional investors own 96.
70% of the company’s stock. Insider Transactions at STAAR Surgical In other news, major shareholder Broadwood Partners, L.P.
bought 3,620 shares of the company’s stock in a transaction dated Thursday, March 27th. The stock was bought at an average price of $17.48 per share, with a total value of $63,277.
60. Following the completion of the acquisition, the insider now owns 12,424,944 shares of the company’s stock, valued at $217,188,021.12.
This represents a 0.03 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link .
Insiders bought a total of 1,128,072 shares of company stock worth $18,842,293 over the last quarter. Company insiders own 1.00% of the company’s stock.
Wall Street Analyst Weigh In Get Our Latest Report on STAAR Surgical STAAR Surgical Stock Performance Shares of STAA opened at $15.92 on Friday. The firm has a market cap of $785.
25 million, a P/E ratio of -38.83 and a beta of 0.75.
STAAR Surgical has a 52 week low of $13.50 and a 52 week high of $52.68.
The firm’s 50-day simple moving average is $18.82 and its 200 day simple moving average is $24.71.
STAAR Surgical Company Profile ( Free Report ) STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. Featured Articles Want to see what other hedge funds are holding STAA? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for STAAR Surgical ( NASDAQ:STAA – Free Report ). Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter .
.
